Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 1, 2012, Pages 142-153

  Kennedy, N A ^a   Clark, D N ^b   Bauer, J ^b   Crowe, A M ^c   Knight, A D ^c   Nicholls, R J ^d   Satsangi, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INFORMATION SERVICES DIVISION   (United Kingdom)

^c Corvus Communications Ltd ^*  (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; DEMOGRAPHY; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL ISOLATION; UNITED KINGDOM;

ADULT; AGED; CAUSE OF DEATH; CROHN DISEASE; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SCOTLAND; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 83555162564     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04906.x     Document Type: Article

References (34)

1. Gunesh S, Thomas GAO, Williams GT, Roberts A, Hawthorne AB,. The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005. Aliment Pharmacol Ther 2008; 27: 211-9.
2. Henderson P, Hansen R, Cameron FL, et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2011 [Epub ahead of print].
3. Loftus EV Jr,. Crohn's disease: why the disparity in mortality? Gut 2006; 55: 447-9.
4. Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T,. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 2010; 16: 347-53.
5. Canavan C, Abrams KR, Mayberry JF,. Meta-analysis: mortality in Crohn's disease. Aliment Pharmacol Ther 2007; 25: 861-70. (Pubitemid 46525338)
6. Roberts SE, Williams JG, Yeates D, Goldacre MJ,. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007; 335: 1033.
7. Nicholls RJ, Clark DN, Kelso L, et al. Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Aliment Pharmacol Ther 2010; 31: 1310-21.
8. Kendrick S, Clarke J,. The Scottish record linkage system. Health Bull 1993; 51: 72-9.
9. The West of Scotland Coronary Prevention Study Group. Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J Clin Epidemiol 1995; 48: 1441-52.
10. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476-80. (Pubitemid 29204365)
11. McMahon AJ, Fischbacher CM, Frame SH, MacLeod MC,. Impact of laparoscopic cholecystectomy: a population-based study. Lancet 2000; 356: 1632-7.
12. Kang JY, Elders A, Majeed A, Maxwell JD, Bardhan KD,. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006; 24: 65-79. (Pubitemid 43894006)
13. Connecting for Health. OPCS-4 Classification. 2011. Available at:. Accessed October 27, 2011.
14. The Scottish Government Statistics. Scottish Index of Multiple Deprivation. 2009. Available at:. Accessed October 27, 2011.
15. Picco MF, Cangemi JR,. Inflammatory bowel disease in the elderly. Gastroenterol Clin N Am 2009; 38: 447-62.
16. Burns EM, Bottle A, Aylin P, Darzi A, Nicholls RJ, Faiz O,. Variation in reoperation after colorectal surgery in England as an indicator of surgical performance: retrospective analysis of Hospital Episode Statistics. BMJ 2011; 343: d4836.
17. Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J,. Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health 2003; 57: 301-9. (Pubitemid 36399121)
18. Brown D, Leyland AH,. Scottish mortality rates 2000-2002 by deprivation and small area population mobility. Soc Sci Med 2010; 71: 1951-7.
19. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G,. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665-72. (Pubitemid 14122134)
20. Onali S, Petruzziello C, Calabrese E, et al. Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic. J Gastrointest Surg 2009; 13: 246-52.
21. Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010; 4: 63-101.
22. de Silva S, Ma C, Proulx M-C, et al. Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2011; 9: 972-80.
23. Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE,. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008; 134: 680-7.
24. Mirjafari H, Al-Husain A, Bruce IN,. Cardiovascular risk factors in inflammatory arthritis. Curr Opin Lipidol 2011; 22: 296-301.
25. Symmons DPM, Gabriel SE,. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011; 7: 399-408.
26. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J,. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 2011; 27: 174-82.
27. Sridhar ARM, Parasa S, Navaneethan U, Crowell MD, Olden K,. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011; 5: 287-94.
28. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-9. (Pubitemid 34621118)
29. Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006; 130: 323-33; quiz 591.
30. Sandborn WJ, Feagan BG, Stoinov S, et al. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007; 357: 228-38. (Pubitemid 47080387)
31. Danese S, Colombel J-F, Reinisch W, Rutgeerts PJ,. Review article: infliximab for Crohn's disease treatment-shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther 2011; 33: 857-69.
32. Lee TW, Fedorak RN,. Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology. Gastroenterol Clin N Am 2010; 39: 543-57.
33. Leombruno JP, Nguyen GC, Grootendorst P, Juurlink D, Einarson T,. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis. Pharmacoepidemiol Drug Saf 2011; 20: 838-48.
34. Tan JJY, Tjandra JJ,. Laparoscopic surgery for Crohn's disease: a meta-analysis. Dis Colon Rectum 2007; 50: 576-85. (Pubitemid 46870468)